Literature DB >> 28784597

Modulating NAD+ metabolism, from bench to bedside.

Elena Katsyuba1, Johan Auwerx2.   

Abstract

Discovered in the beginning of the 20th century, nicotinamide adenine dinucleotide (NAD+) has evolved from a simple oxidoreductase cofactor to being an essential cosubstrate for a wide range of regulatory proteins that include the sirtuin family of NAD+-dependent protein deacylases, widely recognized regulators of metabolic function and longevity. Altered NAD+ metabolism is associated with aging and many pathological conditions, such as metabolic diseases and disorders of the muscular and neuronal systems. Conversely, increased NAD+ levels have shown to be beneficial in a broad spectrum of diseases. Here, we review the fundamental aspects of NAD+ biochemistry and metabolism and discuss how boosting NAD+ content can help ameliorate mitochondrial homeostasis and as such improve healthspan and lifespan.
© 2017 The Authors.

Entities:  

Keywords:  aging; metabolic disorders; neurodegeneration; nicotinamide adenine dinucleotide; poly ADP‐ribose polymerase

Mesh:

Substances:

Year:  2017        PMID: 28784597      PMCID: PMC5599801          DOI: 10.15252/embj.201797135

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  195 in total

1.  Altered tryptophan metabolism in mice with herpes simplex virus encephalitis: increases in spinal cord quinolinic acid.

Authors:  J F Reinhard
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

2.  CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism.

Authors:  Juliana Camacho-Pereira; Mariana G Tarragó; Claudia C S Chini; Veronica Nin; Carlos Escande; Gina M Warner; Amrutesh S Puranik; Renee A Schoon; Joel M Reid; Antonio Galina; Eduardo N Chini
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

3.  Protective effect of nicotinamide adenine dinucleotide (NAD+) against spinal cord ischemia-reperfusion injury via reducing oxidative stress-induced neuronal apoptosis.

Authors:  Lei Xie; Zhenfei Wang; Changwei Li; Kai Yang; Yu Liang
Journal:  J Clin Neurosci       Date:  2016-11-23       Impact factor: 1.961

4.  Glutamine-dependent NAD+ synthetase. How a two-domain, three-substrate enzyme avoids waste.

Authors:  Marzena Wojcik; Heather F Seidle; Pawel Bieganowski; Charles Brenner
Journal:  J Biol Chem       Date:  2006-09-05       Impact factor: 5.157

5.  Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial function.

Authors:  Lori Klaidman; Maria Morales; Seyha Kem; Jun Yang; Mei-Ling Chang; James D Adams
Journal:  Pharmacology       Date:  2003-11       Impact factor: 2.547

6.  Structural characterization of a human cytosolic NMN/NaMN adenylyltransferase and implication in human NAD biosynthesis.

Authors:  Xuejun Zhang; Oleg V Kurnasov; Subramanian Karthikeyan; Nick V Grishin; Andrei L Osterman; Hong Zhang
Journal:  J Biol Chem       Date:  2003-02-06       Impact factor: 5.157

7.  Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt.

Authors:  Marcella Fulco; Yana Cen; Po Zhao; Eric P Hoffman; Michael W McBurney; Anthony A Sauve; Vittorio Sartorelli
Journal:  Dev Cell       Date:  2008-05       Impact factor: 12.270

8.  P7C3 neuroprotective chemicals block axonal degeneration and preserve function after traumatic brain injury.

Authors:  Terry C Yin; Jeremiah K Britt; Héctor De Jesús-Cortés; Yuan Lu; Rachel M Genova; Michael Z Khan; Jaymie R Voorhees; Jianqiang Shao; Aaron C Katzman; Paula J Huntington; Cassie Wassink; Latisha McDaniel; Elizabeth A Newell; Laura M Dutca; Jacinth Naidoo; Huxing Cui; Alexander G Bassuk; Matthew M Harper; Steven L McKnight; Joseph M Ready; Andrew A Pieper
Journal:  Cell Rep       Date:  2014-09-15       Impact factor: 9.423

9.  Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle.

Authors:  Eija Pirinen; Carles Cantó; Young Suk Jo; Laia Morato; Hongbo Zhang; Keir J Menzies; Evan G Williams; Laurent Mouchiroud; Norman Moullan; Carolina Hagberg; Wei Li; Silvie Timmers; Ralph Imhof; Jef Verbeek; Aurora Pujol; Barbara van Loon; Carlo Viscomi; Massimo Zeviani; Patrick Schrauwen; Anthony A Sauve; Kristina Schoonjans; Johan Auwerx
Journal:  Cell Metab       Date:  2014-05-08       Impact factor: 27.287

10.  Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome.

Authors:  Carlos Escande; Veronica Nin; Nathan L Price; Verena Capellini; Ana P Gomes; Maria Thereza Barbosa; Luke O'Neil; Thomas A White; David A Sinclair; Eduardo N Chini
Journal:  Diabetes       Date:  2012-11-19       Impact factor: 9.461

View more
  76 in total

Review 1.  Location, Location, Location: Compartmentalization of NAD+ Synthesis and Functions in Mammalian Cells.

Authors:  Xiaolu A Cambronne; W Lee Kraus
Journal:  Trends Biochem Sci       Date:  2020-06-25       Impact factor: 13.807

2.  Cardioprotection by nicotinamide mononucleotide (NMN): Involvement of glycolysis and acidic pH.

Authors:  Sergiy M Nadtochiy; Yves T Wang; Keith Nehrke; Josh Munger; Paul S Brookes
Journal:  J Mol Cell Cardiol       Date:  2018-06-26       Impact factor: 5.000

3.  Extracellular signal-regulated kinase 1/2 regulates NAD metabolism during acute kidney injury through microRNA-34a-mediated NAMPT expression.

Authors:  Justin B Collier; Rick G Schnellmann
Journal:  Cell Mol Life Sci       Date:  2019-12-23       Impact factor: 9.261

4.  Macrophage de novo NAD+ synthesis specifies immune function in aging and inflammation.

Authors:  Paras S Minhas; Ling Liu; Peter K Moon; Amit U Joshi; Christopher Dove; Siddhita Mhatre; Kevin Contrepois; Qian Wang; Brittany A Lee; Michael Coronado; Daniel Bernstein; Michael P Snyder; Marie Migaud; Ravindra Majeti; Daria Mochly-Rosen; Joshua D Rabinowitz; Katrin I Andreasson
Journal:  Nat Immunol       Date:  2018-11-26       Impact factor: 25.606

Review 5.  Mitochondrial Genetic Disorders: Cell Signaling and Pharmacological Therapies.

Authors:  Fatima Djouadi; Jean Bastin
Journal:  Cells       Date:  2019-03-28       Impact factor: 6.600

6.  Dihydronicotinamide riboside is a potent NAD+ concentration enhancer in vitro and in vivo.

Authors:  Yue Yang; Farheen Sultana Mohammed; Ning Zhang; Anthony A Sauve
Journal:  J Biol Chem       Date:  2019-04-04       Impact factor: 5.157

7.  Adipose tissue NAD+ biosynthesis is required for regulating adaptive thermogenesis and whole-body energy homeostasis in mice.

Authors:  Shintaro Yamaguchi; Michael P Franczyk; Maria Chondronikola; Nathan Qi; Subhadra C Gunawardana; Kelly L Stromsdorfer; Lane C Porter; David F Wozniak; Yo Sasaki; Nicholas Rensing; Michael Wong; David W Piston; Samuel Klein; Jun Yoshino
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-06       Impact factor: 11.205

8.  Evaluation of the NAD+ biosynthetic pathway in ALS patients and effect of modulating NAD+ levels in hSOD1-linked ALS mouse models.

Authors:  Benjamin A Harlan; Kelby M Killoy; Mariana Pehar; Liping Liu; Johan Auwerx; Marcelo R Vargas
Journal:  Exp Neurol       Date:  2020-01-31       Impact factor: 5.330

9.  Mechanistic Biomarkers in Toxicology

Authors:  Sonia Sanajou; Gönül Şahin
Journal:  Turk J Pharm Sci       Date:  2021-06-18

Review 10.  Eukaryotic RNA 5'-End NAD+ Capping and DeNADding.

Authors:  Megerditch Kiledjian
Journal:  Trends Cell Biol       Date:  2018-03-12       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.